Alpha 2.0
Login Register
» Authors » Veronica Marconi

Veronica Marconi

Explore the profile of Veronica Marconi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 115
Followers 0
Related Specialties
General Medicine
Science
Neurology
Top 10 Co-Authors
Roberta Lattanzi
Lucia Negri
Daniela Maftei
Gianfranco Balboni
Severo Salvadori
Cinzia Severini
Robert Nistico
Ilaria Fusco
Fulvio Florenzano
Caterina Scuderi
Published In
Front Pharmacol
Sci Rep
Eur J Med Chem
PLoS One
Biomed Res Int
Affiliations
Soon will be listed here.
Recent Articles
1.
The prokineticin receptor antagonist PC1 rescues memory impairment induced by β amyloid administration through the modulation of prokineticin system
Maftei D, Ratano P, Fusco I, Marconi V, Squillace S, Negri L, et al.
Neuropharmacology . 2019 Aug; 158:107739. PMID: 31408628
Growing evidences demonstrate that chemokines and chemokine receptors are up-regulated in resident central nervous system cells during Alzheimer's disease contributing to neuroinflammation and neurodegeneration. Prokineticin 2 belongs to a new...
2.
Maternal exposure to low levels of corticosterone during lactation protects adult rat progeny against TNBS-induced colitis: A study on GR-mediated anti-inflammatory effect and prokineticin system
Zinni M, Zuena A, Marconi V, Petrella C, Fusco I, Giuli C, et al.
PLoS One . 2017 Mar; 12(3):e0173484. PMID: 28267767
The early phase of life represents a critical period for the development of an organism. Interestingly, early life experiences are able to influence the development of the gastrointestinal tract and...
3.
Bv8/prokineticin 2 is involved in Aβ-induced neurotoxicity
Severini C, Lattanzi R, Maftei D, Marconi V, Ciotti M, Passeri P, et al.
Sci Rep . 2015 Oct; 5:15301. PMID: 26477583
Bv8/Prokineticin 2 (PROK2) is a bioactive peptide initially discovered as a regulator of gastrointestinal motility. Among multiple biological roles demonstrated for PROK2, it was recently established that PROK2 is an...
4.
Prokineticin 2 upregulation in the peripheral nervous system has a major role in triggering and maintaining neuropathic pain in the chronic constriction injury model
Lattanzi R, Maftei D, Marconi V, Florenzano F, Franchi S, Borsani E, et al.
Biomed Res Int . 2015 Feb; 2015:301292. PMID: 25685780
The new chemokine Prokineticin 2 (PROK2) and its receptors (PKR1 and PKR2) have a role in inflammatory pain and immunomodulation. Here we identified PROK2 as a critical mediator of neuropathic...
5.
A new convenient synthetic method and preliminary pharmacological characterization of triazinediones as prokineticin receptor antagonists
Congiu C, Onnis V, Deplano A, Salvadori S, Marconi V, Maftei D, et al.
Eur J Med Chem . 2014 May; 81:334-40. PMID: 24852280
A new efficient synthetic method to obtain prokineticin receptor antagonists based on the triazinedione scaffold is described. In this procedure the overall yield improves from 13% to about 54%, essentially...
6.
Age-related changes of protein SUMOylation balance in the AβPP Tg2576 mouse model of Alzheimer's disease
Nistico R, Ferraina C, Marconi V, Blandini F, Negri L, Egebjerg J, et al.
Front Pharmacol . 2014 Apr; 5:63. PMID: 24778618
Alzheimer's disease (AD) is a complex disorder that affects the central nervous system causing a severe neurodegeneration. This pathology affects an increasing number of people worldwide due to the overall...